Renal colocalisation of Rosai-Dorfman-Destombes disease and secondary AA amyloidosis successfully treated with lenalidomide and dexamethasone

Affiliations

¹ Department of Nephrology and Organ Transplantation, Referral Centre for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France; Internal Medicine and Clinical Immunology Department, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France. Electronic address: benyahia.r@chu-toulouse.fr.
² Department of Pathology, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.
³ Department of Nephrology and Organ Transplantation, Referral Centre for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France.
⁴ Department of Nephrology and Organ Transplantation, Referral Centre for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France; Paul Sabatier-Toulouse 3 University, Toulouse, France.
⁵ Department of Pathology, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France; Paul Sabatier-Toulouse 3 University, Toulouse, France.
⁶ Internal Medicine and Clinical Immunology Department, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.

Rayane Benyahia et al. Lancet Haematol. 2024 Nov.

. 2024 Nov;11(11):e878.

doi: 10.1016/S2352-3026(24)00271-0.

¹ Department of Nephrology and Organ Transplantation, Referral Centre for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France; Internal Medicine and Clinical Immunology Department, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France. Electronic address: benyahia.r@chu-toulouse.fr.
² Department of Pathology, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.
³ Department of Nephrology and Organ Transplantation, Referral Centre for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France.
⁴ Department of Nephrology and Organ Transplantation, Referral Centre for Rare Kidney Diseases, University Hospital of Toulouse, Toulouse, France; Paul Sabatier-Toulouse 3 University, Toulouse, France.
⁵ Department of Pathology, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France; Paul Sabatier-Toulouse 3 University, Toulouse, France.
⁶ Internal Medicine and Clinical Immunology Department, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.

No abstract available

Conflict of interest statement

Declaration of interests We declare no competing interests.